摘要
急性冠脉综合征病人必须同其他原因的胸痛相鉴别。在处理这种病人时,生化标志物起着一个关键性的作用。该综述将集中于心脏生物标志物的当代进展,包括心脏肌钙蛋白、昏型钠尿肽,未结合游离脂肪酸和心型脂肪酸结合蛋白,以及它们在诊断、预后和治疗中的用途。
Patients with acute coronary syndrome must be identified from other causes of chest pain. Biochemical markers play a pivotal role in the diagnosis and management patients with ACS. This review will focus on current advances in cardiac biomarkers, including cardiac troponin, B-type natriuretic peptide, unbound free fatty acids and heart-type fatty acid binding protein,and their diagnostic,prognostic and therapeutic utility.
出处
《现代检验医学杂志》
CAS
2012年第3期1-5,9,共6页
Journal of Modern Laboratory Medicine